Literature DB >> 17179145

Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo- and heterodimerization analysis by fluorescence resonance energy transfer and co-immunoprecipitation.

Theresa N Operaña1, Robert H Tukey2.   

Abstract

UDP-glucuronosyltransferases (UGTs) are membrane-bound proteins localized to the endoplasmic reticulum and catalyze the formation of beta-d-glucopyranosiduronic acids (glucuronides) using UDP-glucuronic acid and acceptor substrates such as drugs, steroids, bile acids, xenobiotics, and dietary nutrients. Recent biochemical evidence indicates that the UGT proteins may oligomerize in the membrane, but conclusive evidence is still lacking. In the present study, we have used fluorescence resonance energy transfer (FRET) to study UGT1A oligomerization in live cells. This technique demonstrated that UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A7, UGT1A8, UGT1A9, and UGT1A10 self-oligomerize (homodimerize). Heterodimer interactions were also explored, and it was determined that UGT1A1 was capable of binding with UGT1A3, UGT1A4, UGT1A6, UGT1A7, UGT1A8, UGT1A9, and UGT1A10. In addition to the in vivo FRET analysis, UGT1A protein-protein interactions were demonstrated through co-immunoprecipitation experiments. Co-expression of hemagglutinin-tagged and cyan fluorescent protein-tagged UGT1A proteins, followed by immunoprecipitation with anti-hemagglutinin beads, illustrated the potential of each UGT1A protein to homodimerize. Co-immunoprecipitation results also confirmed that UGT1A1 was capable of forming heterodimer complexes with all of the UGT1A proteins, corroborating the FRET results in live cells. These preliminary studies suggest that the UGT1A family of proteins form oligomerized complexes in the membrane, a property that may influence function and substrate selectivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17179145     DOI: 10.1074/jbc.M609417200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Modulation of the human glucuronosyltransferase UGT1A pathway by splice isoform polypeptides is mediated through protein-protein interactions.

Authors:  Judith Bellemare; Mélanie Rouleau; Mario Harvey; Chantal Guillemette
Journal:  J Biol Chem       Date:  2009-12-08       Impact factor: 5.157

2.  NRMT1 knockout mice exhibit phenotypes associated with impaired DNA repair and premature aging.

Authors:  Lindsay A Bonsignore; John G Tooley; Patrick M Van Hoose; Eugenia Wang; Alan Cheng; Marsha P Cole; Christine E Schaner Tooley
Journal:  Mech Ageing Dev       Date:  2015-04-02       Impact factor: 5.432

3.  Overcoming Drug Resistance through the Development of Selective Inhibitors of UDP-Glucuronosyltransferase Enzymes.

Authors:  Michael J Osborne; Luciana Coutinho de Oliveira; Laurent Volpon; Hiba Ahmad Zahreddine; Katherine L B Borden
Journal:  J Mol Biol       Date:  2018-11-11       Impact factor: 5.469

4.  Oligomerization and Catalytic Parameters of Human UDP-Glucuronosyltransferase 1A10: Expression and Characterization of the Recombinant Protein.

Authors:  Kyungbo Kim; Fang Zheng; Chang-Guo Zhan
Journal:  Drug Metab Dispos       Date:  2018-08-15       Impact factor: 3.922

5.  A humanized UGT1 mouse model expressing the UGT1A1*28 allele for assessing drug clearance by UGT1A1-dependent glucuronidation.

Authors:  Hongliang Cai; Nghia Nguyen; Vincent Peterkin; Young-Sun Yang; Kathy Hotz; Deirdre Beaton La Placa; Shujuan Chen; Robert H Tukey; Jeffrey C Stevens
Journal:  Drug Metab Dispos       Date:  2010-02-02       Impact factor: 3.922

6.  Glucuronidation of dihydrotestosterone and trans-androsterone by recombinant UDP-glucuronosyltransferase (UGT) 1A4: evidence for multiple UGT1A4 aglycone binding sites.

Authors:  Jin Zhou; Timothy S Tracy; Rory P Remmel
Journal:  Drug Metab Dispos       Date:  2009-12-09       Impact factor: 3.922

7.  Identification and functional characterization of a novel UDP-glucuronosyltransferase 2A1 splice variant: potential importance in tobacco-related cancer susceptibility.

Authors:  Ryan T Bushey; Philip Lazarus
Journal:  J Pharmacol Exp Ther       Date:  2012-09-13       Impact factor: 4.030

8.  Functional characterization of low-prevalence missense polymorphisms in the UDP-glucuronosyltransferase 1A9 gene.

Authors:  Kristine C Olson; Ryan W Dellinger; Qing Zhong; Dongxiao Sun; Shantu Amin; Thomas E Spratt; Philip Lazarus
Journal:  Drug Metab Dispos       Date:  2009-07-09       Impact factor: 3.922

9.  Evaluation of UGT protein interactions in human hepatocytes: effect of siRNA down regulation of UGT1A9 and UGT2B7 on propofol glucuronidation in human hepatocytes.

Authors:  Camille M Konopnicki; Leslie J Dickmann; Jeffrey M Tracy; Robert H Tukey; Larry C Wienkers; Robert S Foti
Journal:  Arch Biochem Biophys       Date:  2013-04-04       Impact factor: 4.013

10.  Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7.

Authors:  Michael J Miley; Agnieszka K Zielinska; Jeffrey E Keenan; Stacie M Bratton; Anna Radominska-Pandya; Matthew R Redinbo
Journal:  J Mol Biol       Date:  2007-03-30       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.